-
BTIG Research Reaffirms Buy Rating for Humacyte (NASDAQ:HUMA)
Источник: Buzz FX / 18 окт 2024 11:46:13 America/New_York
Written by MarketBeatOctober 18, 2024 ShareLink copied to clipboard. Humacyte (NASDAQ:HUMA - Get Free Report)'s stock had its "buy" rating restated by equities research analysts at BTIG Research in a research report issued on Friday, Benzin
Read more...